Cost-effectiveness analysis of benign prostatic hyperplasia (BPH) treatments

被引:0
|
作者
DiSantostefano, R [1 ]
Biddle, A [1 ]
Lavelle, J [1 ]
机构
[1] Univ N Carolina, Chapel Hill, NC USA
关键词
D O I
10.1016/S1098-3015(10)62773-8
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:301 / 302
页数:2
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of benign prostatic hyperplasia (BPH)treatments
    DiSantostefano, RL
    Biddle, AK
    Lavelle, JP
    JOURNAL OF UROLOGY, 2005, 173 (04): : 8 - 8
  • [2] Cost-effectiveness of dutasteride in the treatment of benign prostatic hyperplasia (BPH)
    Kaczor, M.
    Pawlik, D.
    Becla, L.
    Dardzinski, W.
    Jasinska, A.
    Wojcik, R.
    Walczak, J.
    Nogas, G.
    Cel, M.
    Glogowski, C.
    Zespol-Instytutu, A.
    VALUE IN HEALTH, 2006, 9 (06) : A253 - A254
  • [3] Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia
    Chughtai, Bilal
    Rojanasarot, Sirikan
    Neeser, Kurt
    Gultyaev, Dmitry
    Amorosi, Stacey L.
    Shore, Neal D.
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2021, 8 (01): : 42 - 50
  • [4] Comparison of Minimally Invasive Procedures for Benign Prostatic Hyperplasia: A Cost-effectiveness Analysis
    Wu, Xiao
    Zhou, Alice
    Heller, Michael
    Chi, Thomas
    Kohlbrenner, Ryan
    RADIOLOGY, 2023, 309 (03)
  • [5] COST-EFFECTIVENESS OF COMBINATION THERAPY FOR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
    Baker, T. M.
    Black, L.
    Bjerklund, Johansen T. E.
    VALUE IN HEALTH, 2009, 12 (07) : A309 - A309
  • [6] Cost-effectiveness of Prostate Artery Embolization for Benign Prostatic Hyperplasia
    Gemmete, Joseph J.
    RADIOLOGY, 2023, 309 (03)
  • [7] COMPARING THE COST-EFFECTIVENESS OF A NOVEL MINIMALLY INVASIVE SURGICAL THERAPY FOR BENIGN PROSTATIC HYPERPLASIA (BPH): A SWEDISH PERSPECTIVE
    Zervakis, A.
    Buseghin, G.
    Martin, P.
    Klein, Tm
    Hermansson, Ll
    VALUE IN HEALTH, 2024, 27 (12)
  • [8] The long-term cost effectiveness of treatments for benign prostatic hyperplasia
    DiSantostefano, RL
    Biddle, AK
    Lavelle, JP
    PHARMACOECONOMICS, 2006, 24 (02) : 171 - 191
  • [9] The Long-Term Cost Effectiveness of Treatments for Benign Prostatic Hyperplasia
    Rachael L. DiSantostefano
    Andrea K. Biddle
    John P. Lavelle
    PharmacoEconomics, 2006, 24 : 171 - 191
  • [10] Cost-effectiveness of alternative first- and second-line treatments for benign prostatic hyperplasia in Singapore
    Chay, Junxing
    Tung, Joshua Yi Min
    Su, Rebecca Jade
    Aslim, Edwin Jonathan
    Wong, Callix
    Swan, Georgia
    Chua, Wei Jin
    Ho, Henry Sun Sien
    Finkelstein, Eric Andrew
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1269 - 1277